Related Experiment Videos
Suppression of HIV replication in vitro by fusidic acid parallels cell toxicity
The Journal of Antimicrobial Chemotherapy
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy.
Journal of cancer policy·2021
Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy.
Patient preference and adherence·2011
An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
International journal of immunopathology and pharmacology·2007
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.
Journal of neurology·2005
Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.
The Journal of antimicrobial chemotherapy·2026
HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.
The Journal of antimicrobial chemotherapy·2026
Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.
The Journal of antimicrobial chemotherapy·2026
A prospective pharmacokinetic interaction study between rifampicin and fusidic acid for the treatment of staphylococcal infections.
The Journal of antimicrobial chemotherapy·2026
Influenza mitigation recommendations, symptoms, and viral RNA shedding durations-2023-24 and 2024-25 seasons.
American journal of epidemiology·2026
Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.
Antimicrobial agents and chemotherapy·2026
Urban soils along the Kern River and Los Gatos Creek are hotspots for Coccidioides in the San Joaquin Valley of California.
Applied and environmental microbiology·2026
When tests don't fit the rules: regulatory challenges for agnostic metagenomic next-generation sequencing in infectious diseases diagnostics.
Journal of clinical microbiology·2026